Suchergebnisse - "Virus Diseases"

PubPharm (16.890)

41

COVID-19 vaccine hesitancy among the Chinese elderly : A multi-stakeholder qualitative study

enthalten in: Human vaccines & immunotherapeutics | 2024

von Li, X. | Bai, Y. | Weng, L. | +2

42

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer : Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With HIV Infection, KSHV Infection, Viral-Related Pre-Malignant Lesions, and/or Cancer

enthalten in: ClinicalTrials.gov | 2024

43

Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers : An Open-label, Randomized, Response-adaptive Crossover Study to Investigate the Comparative Pharmacokinetics and Bioequivalence of Aterixen 100 mg Tablets and Aterixen 100 mg Film-coated Tablets in Healthy Volunteers

enthalten in: ClinicalTrials.gov | 2024

44

Nosocomial Influenza Surveillance of 2022 - 2027 Seasonal Period : Surveillance of Nosocomial Influenza at Edouard Herriot University Hospital, Lyon, France

enthalten in: ClinicalTrials.gov | 2024

45

Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010 : Retrospective Study of Viral Reactivation Across All Bone Marrow Transplant Protocols Since 2010

enthalten in: ClinicalTrials.gov | 2024

46

Epidemiological Characterization of Respiratory Pathogens Using the Multiplex PCR FilmArray™ Respiratory Panel

enthalten in: Diagnostics (Basel, Switzerland) | 2024

von Hong, Y. | Jung, B. | Kim, J.

47

The Aim of This Study is to Investigate the Persistence of Antibody Response in Adults up to 15 Years After One Booster Dose of GlaxoSmithKline (GSK) Biologicals' Encepur Adults Vaccine : Long Term Immunogenicity up to 15 Years After the First Booster Immunization With GSK Biologicals' Encepur Adults (Polygeline-free Tick-Borne Encephalitis Vaccine for Adults) in Adults Who Received 1 of 3 Different Primary Vaccination Schedules

enthalten in: ClinicalTrials.gov | 2024

48

A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus Infection : A Phase 1b, Open-label, Single-arm, Multicenter Study to Assess Efficacy, Safety, and Tolerability of Treatment With JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, HBeAg-negative Participants With Chronic Hepatitis B Virus Infection

enthalten in: ClinicalTrials.gov | 2024

49

Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection : Glecaprevir/Pibrentasvir Fixed-dose Combination Treatment for Acute Hepatitis C Virus Infection (PURGE-C)

enthalten in: ClinicalTrials.gov | 2024

50

A Study to Investigate Acute Respiratory Virus Infections in Participants at High Risk for Severe Illness : Prospective Study to Investigate Acute Respiratory Virus Infections in Patients at High Risk for Severe Illness

enthalten in: ClinicalTrials.gov | 2024